BD names Bridget Bagnato as Peripheral Intervention president

BD (Becton, Dickinson and Company) (NYSE: BDX) has appointed Bridget Bagnato as worldwide president of its Peripheral Intervention business unit, effective November 16, according to a company statement.

Bagnato will be based at Peripheral Intervention's headquarters in Tempe, Arizona, where she will oversee the business unit's global strategic, operational, and commercial performance. She will report to Peter Menziuso, executive vice president and president of BD's Interventional segment.

Bagnato currently serves as worldwide president of BD's Specimen Management business unit. She has held leadership roles at BD for more than 27 years, including positions in Medication Delivery Solutions and Surgery, where she was vice president and general manager of Surgical Complication Solutions.

Menziuso said Bagnato "brings deep experience across BD and a strong understanding of our customers, with a proven ability to grow businesses through innovation and operational excellence."

Bagnato holds a bachelor's degree from Villanova University and an MBA from The Fuqua School of Business at Duke University.

You May Also Be Interested In

• BD Names Bridget Bagnato Worldwide President of Peripheral Intervention
• Renesas Electronics makes several executive leadership changes
• Siebert Financial names Gebbia family members to new leadership roles